<< backUK Cardiovascular Seminar Series
Other Seminars/Schedules | Spring 2001 | Fall 2001Fridays 8:00 a.m. - 9:00 a.m.
Department of Medicine Conference Room
J524 - 526
Kentucky Clinic
| Date | Speaker | Institute | Title | Host/Resp. Unit | Sponsor |
|---|---|---|---|---|---|
| 09/07 | Joseph Vita MD | Boston U | Endothelial Dysfunction in Coronary Artery Disease | Daugherty / GHI | Medcon/Pfizer |
| 09/14 | Prakash Narayan PhD | UK | Cardiomyocyte Apoptosis Following Simulated Ischemia-Reperfusion | Lasley / Surgery | |
| 09/21 | David Royston MD | Harefield Hospital, UK | Improving Patient Outcomes; Strategies for the Next Millennium | Ferraris / Surgery | Bayer |
| 09/28 | No seminar | ||||
| 10/05 | Rolando Berger MD | UK | New Issues in Venous Thromboembolism | Moreno / GHI | BMS |
| 10/12 | GHI Cardiovascular Research day - no seminar | ||||
| 10/19 | Kevin Williams MD | Temple | Extracellular matrix and atherosclerosis | Daugherty / Nutri Sci | BMS |
| 10/26 | Sumant Lamba MD | UK | Review of Current Clinical Trials in Heart Failure at UK | Moreno / GHI | BMS |
| 11/02 | Robert Taylor MD PhD | Emory | Role of AngII in the development of atherosclerosis | Daugherty / GHI | Astra Zeneca |
| 11/09 | Thomas Whayne MD, PhD | UK | Aggressive treatment of hypercholesterolmia versus the new NCEP guidelines | Daugherty / GHI | BMS |
| 11/16 | David Hajjar PhD | Cornell | Role of CD36 in Atherosclerosis | Smart / Nutri Sci | |
| 11/23 | Thanksgiving - no seminar | ||||
| 11/30 | Carl Sparrow PhD | Merck | LXR agonist - a new therapeutic approach for dyslipidemias | Daugherty / GHI | Merck |
| 12/07 | Ronald Law PhD | UCLA | PPARs, Lipids, Angiotensin II, and Atherosclerosis | Daugherty / GHI | Medcon/Pfizer |
| 12/14 | Omar Francone PhD | Pfizer | ABCA1: The molecular mechanism underlying HDL mediated cholesterol removal | Daugherty / GHI | Pfizer |
